SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-24-000123
Filing Date
2024-08-12
Accepted
2024-08-12 17:15:31
Documents
1
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1723497325.html 4  
1 FORM 4 wk-form4_1723497325.xml 4 7373
  Complete submission text file 0001439222-24-000123.txt   8903
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address
Goff Brian (Reporting) CIK: 0001546216 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 241197926